Clinical Trial: A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy Participants

U.S., Oct. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07889349) titled 'A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SHR 3201 Injection in Healthy Participants' on Oct. 16.

Brief Summary: This study is a randomized, double-blind, dose-escalation, placebo-controlled Phase I clinical trial in healthy participants to evaluate the safety, tolerability, and pharmacokinetics of single intravenous and subcutaneous administrations of SHR-3201.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Alzheimer's Disease

Intervention: DRUG: SHR 3201 Injection

SHR 3201 injection.

DRUG: SHR 3201 Placebo.

SHR 3201 placebo.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: B...